Spots Global Cancer Trial Database for cytoreductive surgery
Every month we try and update this database with for cytoreductive surgery cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels | NCT04931420 | Metastatic Canc... Foregut Carcino... Gastric Adenoca... Gallbladder Ade... Liver Cancer GI Cancer GI Carcinoma Lung Cancer | Standard of Car... Video-Assisted ... Lobectomy Consolidative R... Ablation Treatm... Resection or Ex... Peritonectomy Transarterial R... | 18 Years - | University of Chicago | |
| Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer | NCT05415709 | Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Primary Periton... Primary Periton... Stage III Fallo... Stage III Ovari... Stage III Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA1 Fal... Stage IIIA1 Ova... Stage IIIA2 Fal... Stage IIIA2 Ova... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... | Carboplatin Cisplatin Cytoreductive S... Hyperthermic In... Paclitaxel Quality-of-Life... Questionnaire A... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Surgery and Heated Chemotherapy for Adrenocortical Carcinoma | NCT01833832 | Adrenocortical ... Peritoneal Carc... | Cisplatin Cytoreductive s... sodium thiosulf... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer | NCT02199171 | FIGO Stage IIC-... Fallopian Tube ... Peritoneal Carc... | carboplatin | 18 Years - | University of California, Irvine | |
| Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis | NCT03023436 | Stomach Neoplas... | Cytoreductive s... Hyperthermic In... Fluoropyrimidin... Cisplatin | 19 Years - 74 Years | Nanfang Hospital, Southern Medical University | |
| Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis | NCT04547725 | Gastric Cancer Peritoneal Carc... | CRS followed by... | 20 Years - 75 Years | National Taiwan University Hospital | |
| Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy | NCT05597683 | Cytoreductive S... Hyperthermic In... Peritoneal Canc... | Arm I (QL block... | 19 Years - | Gangnam Severance Hospital | |
| A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer | NCT03245892 | High Grade Sero... Fallopian Tube Primary Periton... | Carboplatin and... Nivolumab Cytoreductive s... Ipilimumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| PROADAPT-ovary/EWOC-2 | NCT04284969 | Ovarian Cancer Surgery | PROADAPT progra... | 70 Years - | Hospices Civils de Lyon | |
| EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas | NCT01257594 | Brain Cancer | erlotinib Cytoreductive S... | 18 Years - | Columbia University | |
| Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis | NCT02399410 | Colorectal Neop... | perioperative c... cytoreductive s... Intraperitoneal... | 18 Years - | University Hospital, Ghent | |
| Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver | NCT05610826 | Pancreatic Neur... Pancreas Cancer | cytoreductive s... Lutathera - a s... Peptide recepto... | 18 Years - | University of Chicago | |
| Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery | NCT03373058 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Hyperthermic In... cytoreductive s... adjuvant chemot... | 18 Years - 70 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| Results of CRS and Debulking in PMP Patients | NCT01427101 | Pseudomyxoma Pe... | 20 Years - 80 Years | Uppsala University | ||
| Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec) | NCT01882920 | Primary Periton... Secondary Perit... | Goal Directed I... Conventional In... | 18 Years - | Regina Elena Cancer Institute | |
| Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer | NCT01442051 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Acute Normovole... | 18 Years - 69 Years | Memorial Sloan Kettering Cancer Center | |
| Lactate and Complications in Cytoreduction Surgery for Peritoneal Carcinomatosis | NCT04307654 | Lactacidemia an... | - | Hospital General Universitario de Castellón | ||
| Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer | NCT05633199 | Cytoreductive S... | cytoreductive s... | 18 Years - 70 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy | NCT01998529 | Lung Cancer | Cisplatin Amifostine | 3 Years - 21 Years | M.D. Anderson Cancer Center | |
| Results of CRS and Debulking in PMP Patients | NCT01427101 | Pseudomyxoma Pe... | 20 Years - 80 Years | Uppsala University | ||
| Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis | NCT04122885 | Peritoneal Canc... Chemotherapy-In... | PIPAC with oxal... Cytoreductive s... | 18 Years - | University Hospital Tuebingen | |
| Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis | NCT00454519 | Stomach Neoplas... Colorectal Neop... Neoplasm Metast... Mesothelioma | cytoreductive s... intraoperative ... | 20 Years - 70 Years | Wuhan University | |
| Inferior Epigastric Lymp Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Ovarian Peritoneal Metastases | NCT06237582 | Carcinomatosis,... | epigastric lymp... | 18 Years - | Jules Bordet Institute | |
| Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients | NCT04213794 | Malignant Abdom... Malignant Pelvi... Recurrent Colon... Recurrent Desmo... Recurrent Fallo... Recurrent Gastr... Recurrent Lipos... Recurrent Malig... Recurrent Ovari... Recurrent Prima... Recurrent Recta... Recurrent Rhabd... Recurrent Sarco... Refractory Colo... Refractory Desm... Refractory Fall... Refractory Gast... Refractory Lipo... Refractory Mali... Refractory Ovar... Refractory Prim... Refractory Rect... Refractory Rhab... Refractory Sarc... Resectable Lipo... Resectable Mali... Resectable Sarc... | Cisplatin Cytoreductive S... Doxorubicin Hyperthermic In... Sodium Thiosulf... Computed Tomogr... Magnetic Resona... Positron Emissi... Biospecimen Col... | 1 Year - 25 Years | Mayo Clinic | |
| Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy | NCT01998529 | Lung Cancer | Cisplatin Amifostine | 3 Years - 21 Years | M.D. Anderson Cancer Center | |
| CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma | NCT04727242 | LMS - Leiomyosa... Uterine Leiomyo... | Gemcitabine Dacarbazine Cytoreductive S... Functional Asse... Computed Tomogr... Gadolinium | 18 Years - | Stanford University | |
| Combined Anticancer Treatment of Advanced Colon Cancer | NCT01540344 | Peritoneal Carc... Colorectal Canc... | CRS HIPEC | 18 Years - 71 Years | University of Regensburg | |
| SOPHIE Trial: Surgery in Ovarian Cancer With PreHabilitation In ERAS | NCT04862325 | Advanced Ovaria... | Multimodal Preh... | 18 Years - | Hospital Clinic of Barcelona | |
| Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer | NCT05633199 | Cytoreductive S... | cytoreductive s... | 18 Years - 70 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT03188432 | Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... | Carboplatin Quality-of-Life... Questionnaire A... Cytoreductive S... | 18 Years - | Wake Forest University Health Sciences | |
| Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma | NCT00820157 | Hepatocellular ... | Cytoreductive S... TACE | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma | NCT05001880 | Peritoneal Mali... | Atezolizumab Bevacizumab Biospecimen Col... Carboplatin Computed Tomogr... Cytoreductive S... Hyperthermic In... Pemetrexed Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| SOPHIE Trial: Surgery in Ovarian Cancer With PreHabilitation In ERAS | NCT04862325 | Advanced Ovaria... | Multimodal Preh... | 18 Years - | Hospital Clinic of Barcelona | |
| Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis | NCT03023436 | Stomach Neoplas... | Cytoreductive s... Hyperthermic In... Fluoropyrimidin... Cisplatin | 19 Years - 74 Years | Nanfang Hospital, Southern Medical University | |
| Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis | NCT04547725 | Gastric Cancer Peritoneal Carc... | CRS followed by... | 20 Years - 75 Years | National Taiwan University Hospital | |
| Inferior Epigastric Lymph Node in Colorectal Carcinosis | NCT04966715 | Colorectal Carc... | Epigastric lymp... | 18 Years - 99 Years | Jules Bordet Institute | |
| Combined Anticancer Treatment of Advanced Colon Cancer | NCT01540344 | Peritoneal Carc... Colorectal Canc... | CRS HIPEC | 18 Years - 71 Years | University of Regensburg | |
| Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma | NCT05001880 | Peritoneal Mali... | Atezolizumab Bevacizumab Biospecimen Col... Carboplatin Computed Tomogr... Cytoreductive S... Hyperthermic In... Pemetrexed Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| Results of CRS and Debulking in PMP Patients | NCT01427101 | Pseudomyxoma Pe... | 20 Years - 80 Years | Uppsala University | ||
| Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies | NCT00625092 | Peritoneal Cavi... | fluorouracil leucovorin calc... oxaliplatin cytoreductive s... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) | NCT05913674 | Peritoneal Carc... Appendiceal Neo... Colorectal Canc... | Modified early ... | 18 Years - | Ciusss de L'Est de l'Île de Montréal | |
| What Are the Experiences of Patients With Pseudomyxoma Peritonei? | NCT04125225 | Pseudomyxoma Pe... Cytoreductive S... Recovery | 16 Years - | University of Southampton | ||
| Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer | NCT05431530 | Ovarian Cancer Low Anterior Re... Quality of Life | Cytoreductive s... | 18 Years - | Seoul National University Hospital | |
| Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy | NCT02741167 | Peritoneal Canc... | CRS and HIPEC | 18 Years - | University of Zurich | |
| ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis | NCT01815359 | Appendix Cancer Colorectal Canc... | Cytoreductive S... HIPEC with Mito... EPIC with FUDR ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| What Are the Experiences of Patients With Pseudomyxoma Peritonei? | NCT04125225 | Pseudomyxoma Pe... Cytoreductive S... Recovery | 16 Years - | University of Southampton | ||
| ECO-LEAK Technique: Early Detection of Colorectal Anastomotic Leakage by Transvaginal Ultrasound | NCT05942209 | Gynecologic Can... Anastomotic Lea... Cytoreductive S... | ECO-LEAK transv... ECO-LEAK with C... CT-Scan or rect... | 21 Years - 99 Years | Instituto de Investigacion Sanitaria La Fe | |
| Fluid Balance During Surgery for Ovarian Cancer | NCT03006939 | Ovarian Neoplas... Fluid Therapy | Cytoreductive s... | 18 Years - | University Hospital, Bonn | |
| Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | NCT00331422 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | carboplatin paclitaxel cytoreductive s... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer Index | NCT05063019 | Hyperthermic In... Cytoreductive S... Peritoneal Carc... | MRI | 20 Years - 80 Years | Chang Gung Memorial Hospital | |
| Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy | NCT02741167 | Peritoneal Canc... | CRS and HIPEC | 18 Years - | University of Zurich | |
| Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis | NCT01524094 | Colorectal Peri... | Systemic chemot... Cytoreductive s... | 18 Years - 80 Years | Uppsala University | |
| Immunotoxin in Peritoneal Carcinomatosis- ImmunoPeCa Trial | NCT02219893 | Colorectal Neop... | MOC31PE Immunot... | 18 Years - | Oslo University Hospital | |
| CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma | NCT04727242 | LMS - Leiomyosa... Uterine Leiomyo... | Gemcitabine Dacarbazine Cytoreductive S... Functional Asse... Computed Tomogr... Gadolinium | 18 Years - | Stanford University | |
| Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment | NCT04744688 | Peritoneal Meta... Peritoneal Carc... Colorectal Neop... Intestinal Neop... Cytoreductive S... Venous Thromboe... Bleeding Laparoscopic Su... Coagulation Surgical Proced... Postoperative C... Laparoscopy Minimally Invas... Surgical Oncolo... | 18 Years - | University of Aarhus | ||
| Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer | NCT01826227 | Ovarian Cancer Fallopian Tube Primary Periton... | Positron Emissi... 18F-Fluoro-2-de... Cytoreductive s... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin | NCT05375825 | Malignant Pleur... Malignant Pleur... Epithelial Tumo... Pleural Effusio... Mesothelin (Msl... | Cytoreductive s... LMB-100 Immunohistochem... | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) | NCT05123807 | Ovarian Cancer | Cytoreductive s... | 18 Years - | M.D. Anderson Cancer Center | |
| Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin | NCT05375825 | Malignant Pleur... Malignant Pleur... Epithelial Tumo... Pleural Effusio... Mesothelin (Msl... | Cytoreductive s... LMB-100 Immunohistochem... | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Fluid Balance During Surgery for Ovarian Cancer | NCT03006939 | Ovarian Neoplas... Fluid Therapy | Cytoreductive s... | 18 Years - | University Hospital, Bonn | |
| Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies | NCT02073500 | Pseudomyxoma Pe... Colorectal Carc... Ovarian Carcino... Mesothelioma | Observational s... | 18 Years - | Oslo University Hospital | |
| Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases | NCT05353582 | Colorectal Neop... Colorectal Canc... Colorectal Canc... Peritoneal Meta... Peritoneal Canc... Peritoneal Neop... Chemotherapy Ef... Cytoreductive S... Hyperthermic In... | Preoperative sy... CRS+HIPEC Postoperative c... Postoperative c... | 18 Years - 75 Years | Sun Yat-sen University | |
| Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients | NCT04213794 | Malignant Abdom... Malignant Pelvi... Recurrent Colon... Recurrent Desmo... Recurrent Fallo... Recurrent Gastr... Recurrent Lipos... Recurrent Malig... Recurrent Ovari... Recurrent Prima... Recurrent Recta... Recurrent Rhabd... Recurrent Sarco... Refractory Colo... Refractory Desm... Refractory Fall... Refractory Gast... Refractory Lipo... Refractory Mali... Refractory Ovar... Refractory Prim... Refractory Rect... Refractory Rhab... Refractory Sarc... Resectable Lipo... Resectable Mali... Resectable Sarc... | Cisplatin Cytoreductive S... Doxorubicin Hyperthermic In... Sodium Thiosulf... Computed Tomogr... Magnetic Resona... Positron Emissi... Biospecimen Col... | 1 Year - 25 Years | Mayo Clinic | |
| Defining Inflammation Related to Peritoneal Carcinomatosis in Women With Ovarian or Colon Cancer. | NCT04122937 | Peritoneal Carc... Ovarian Cancer Colon Cancer | Cytoreductive s... | 25 Years - 75 Years | University of Pisa | |
| A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer | NCT03245892 | High Grade Sero... Fallopian Tube Primary Periton... | Carboplatin and... Nivolumab Cytoreductive s... Ipilimumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer | NCT01628380 | Ovarian Neoplas... | Cytoreductive S... CRS alone | 18 Years - 70 Years | A.O. Ospedale Papa Giovanni XXIII | |
| MicroFluO: FLUorescence-guided Surgery for Ovarian Cancer | NCT05633836 | Ovarian Cancer | Fluorescence gu... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | NCT00331422 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | carboplatin paclitaxel cytoreductive s... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer | NCT01628380 | Ovarian Neoplas... | Cytoreductive S... CRS alone | 18 Years - 70 Years | A.O. Ospedale Papa Giovanni XXIII | |
| Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer | NCT01628380 | Ovarian Neoplas... | Cytoreductive S... CRS alone | 18 Years - 70 Years | A.O. Ospedale Papa Giovanni XXIII | |
| Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy | NCT06351475 | Peritoneal Neop... Hyperthermic In... Intraoperative ... Fluid Therapy Postoperative C... | Intra-operative... Control | 18 Years - 80 Years | Assistance Publique - Hôpitaux de Paris | |
| PROADAPT-ovary/EWOC-2 | NCT04284969 | Ovarian Cancer Surgery | PROADAPT progra... | 70 Years - | Hospices Civils de Lyon | |
| MicroFluO: FLUorescence-guided Surgery for Ovarian Cancer | NCT05633836 | Ovarian Cancer | Fluorescence gu... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma | NCT00820157 | Hepatocellular ... | Cytoreductive S... TACE | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery | NCT03373058 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Hyperthermic In... cytoreductive s... adjuvant chemot... | 18 Years - 70 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer | NCT01116791 | Peritoneal Carc... Gastrointestina... | Cytoreductive S... | 18 Years - 75 Years | University Hospital, Gasthuisberg | |
| Immunotoxin in Peritoneal Carcinomatosis- ImmunoPeCa Trial | NCT02219893 | Colorectal Neop... | MOC31PE Immunot... | 18 Years - | Oslo University Hospital | |
| Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy | NCT02741167 | Peritoneal Canc... | CRS and HIPEC | 18 Years - | University of Zurich | |
| Psychological distREsS hipEc oR pelVic Exenteration | NCT04956107 | Colo-rectal Can... | 18 Years - | University of Aarhus | ||
| Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies | NCT00625092 | Peritoneal Cavi... | fluorouracil leucovorin calc... oxaliplatin cytoreductive s... | 18 Years - | Masonic Cancer Center, University of Minnesota |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
